WO2016159581A3 - Composition for innate immunity enhancement and antiviral activity containing aster tataricus extract as active ingredient - Google Patents

Composition for innate immunity enhancement and antiviral activity containing aster tataricus extract as active ingredient Download PDF

Info

Publication number
WO2016159581A3
WO2016159581A3 PCT/KR2016/003039 KR2016003039W WO2016159581A3 WO 2016159581 A3 WO2016159581 A3 WO 2016159581A3 KR 2016003039 W KR2016003039 W KR 2016003039W WO 2016159581 A3 WO2016159581 A3 WO 2016159581A3
Authority
WO
WIPO (PCT)
Prior art keywords
innate immunity
antiviral activity
immunity enhancement
enhancement
composition
Prior art date
Application number
PCT/KR2016/003039
Other languages
French (fr)
Korean (ko)
Other versions
WO2016159581A2 (en
Inventor
마진열
조원경
이종수
Original Assignee
한국 한의학 연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국 한의학 연구원 filed Critical 한국 한의학 연구원
Publication of WO2016159581A2 publication Critical patent/WO2016159581A2/en
Publication of WO2016159581A3 publication Critical patent/WO2016159581A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a pharmaceutical composition for innate immunity enhancement and antiviral activity containing an Aster tataricus extract as an active ingredient, a health functional food for innate immunity enhancement and antiviral activity containing an Aster tataricus extract as an active ingredient, a feed composition for innate immunity enhancement and antiviral activity containing an Aster tataricus extract as an active ingredient, and a method for innate immunity enhancement and antiviral activity enhancement in an animal, the method comprising administering an Aster tataricus extract to an animal excluding humans, in need of innate immunity enhancement. The Aster tataricus-containing composition for innate immunity enhancement and antiviral activity according to the present invention exhibits antiviral activity and innate immunity enhancement efficacy, and thus can be applied for prevention and treatment of bacterial and viral infectious diseases, and can be widely used for a medicine or a health functional food for immunity enhancement and regulation in immunodeficient or immunosuppressed patients and for a feed for innate immunity enhancement and antiviral activity, for the purpose of anti-disease enhancement of animals. Furthermore, the composition for innate immunity enhancement and antiviral activity according to the present invention scarcely causes toxicity or side effects, and thus can be safely used even in the long-term use for prophylactic purposes.
PCT/KR2016/003039 2015-03-27 2016-03-25 Composition for innate immunity enhancement and antiviral activity containing aster tataricus extract as active ingredient WO2016159581A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150042940 2015-03-27
KR10-2015-0042940 2015-03-27

Publications (2)

Publication Number Publication Date
WO2016159581A2 WO2016159581A2 (en) 2016-10-06
WO2016159581A3 true WO2016159581A3 (en) 2016-12-01

Family

ID=57006974

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/003039 WO2016159581A2 (en) 2015-03-27 2016-03-25 Composition for innate immunity enhancement and antiviral activity containing aster tataricus extract as active ingredient

Country Status (2)

Country Link
KR (1) KR101800443B1 (en)
WO (1) WO2016159581A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000122A (en) * 1991-06-03 1993-01-15 김성호 Treatment of acquired immunodeficiency syndrome (Aequired Immune Deficiency Syndrome) and preparation method thereof
KR20040065498A (en) * 2003-01-14 2004-07-22 주식회사 엘지생활건강 Allergic dermatitis and skin itching relieving composition containing natural herb extract
KR100543355B1 (en) * 2005-05-17 2006-01-20 김성호 A Herb extract
CN101181561A (en) * 2007-12-10 2008-05-21 金陵药业股份有限公司 Chinese medicine as well as preparation method and application thereof
CN102657804A (en) * 2012-05-21 2012-09-12 深圳市齐旺投资有限公司 Traditional Chinese medical composition for treatment of viral influenza and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100434001C (en) * 2004-11-26 2008-11-19 李忠 Aster health-care cigarette with harm decreasement
CN103145792B (en) 2013-03-25 2016-03-09 中国科学院昆明植物研究所 Shionone type triterpene and pharmaceutical composition thereof and its preparation method and application

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000122A (en) * 1991-06-03 1993-01-15 김성호 Treatment of acquired immunodeficiency syndrome (Aequired Immune Deficiency Syndrome) and preparation method thereof
KR20040065498A (en) * 2003-01-14 2004-07-22 주식회사 엘지생활건강 Allergic dermatitis and skin itching relieving composition containing natural herb extract
KR100543355B1 (en) * 2005-05-17 2006-01-20 김성호 A Herb extract
CN101181561A (en) * 2007-12-10 2008-05-21 金陵药业股份有限公司 Chinese medicine as well as preparation method and application thereof
CN102657804A (en) * 2012-05-21 2012-09-12 深圳市齐旺投资有限公司 Traditional Chinese medical composition for treatment of viral influenza and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LU , N. ET AL.: "Gene Expression Profiles Underlying Selective T- Cell -Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 2014, no. 976364, 8 January 2010 (2010-01-08), pages 1 - 15 *

Also Published As

Publication number Publication date
KR101800443B1 (en) 2017-11-22
WO2016159581A2 (en) 2016-10-06
KR20160115824A (en) 2016-10-06

Similar Documents

Publication Publication Date Title
PH12018500044A1 (en) Stuffy nose deblocking composition having antiviral activity
WO2017022962A8 (en) Composition for preventing or treating immune disease, comprising ripk inhibitor as active ingredient
MX2021013139A (en) Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient.
WO2016159582A3 (en) Composition for innate immunity enhancement and antiviral activity containing schizonepeta tenuifolia extract as active ingredient
EP4218823A3 (en) Novel polymeric hgh prodrugs
MX2018008645A (en) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
MX2018000092A (en) New bicyclic lipolantipeptide, preparation and use as antimicrobial agent.
WO2016159583A3 (en) Composition for innate immunity enhancement and antiviral activity containing hovenia dulcis extract as active ingredient
WO2015048188A8 (en) Modified fibroblast growth factors for the treatment of ocular disorders
WO2016159584A3 (en) Composition for innate immunity enhancement and antiviral activity containing extract of mori ramulus or mori radicis cortex as active ingredient
WO2018093237A3 (en) Composition comprising formic acid or pharmaceutically acceptable salt thereof as active ingredient for preventing or treating obesity or metabolic syndromes caused by obesity
RU2014117294A (en) 4,6-DI (3,12-DIAZA-6,9-DIAZONIADISPIRO [5.2.5.2] HEXADECAN-1-IL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF CHEMISE
NZ599039A (en) Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry
MX2018004796A (en) Preservation of water-soluble vitamins.
PH12017500743A1 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
MY194024A (en) Use of cistanche tubulosa extract and isoacteoside in protection of muscles
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
BR112017016278A2 (en) Prevention and/or the medical treatment agent of immunopathy
ZA201905309B (en) Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
WO2016159581A3 (en) Composition for innate immunity enhancement and antiviral activity containing aster tataricus extract as active ingredient
MX2018011539A (en) Treatment of skin conditions and diseases associated with microbial biofilms.
GB2550750A (en) Anthelmintic compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16773362

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16773362

Country of ref document: EP

Kind code of ref document: A2